Latin America Home Healthcare Market by Size, Share, Forecasts, & Trends Analysis
‘Latin
America Home Healthcare Market by Product (Equipment [Therapeutic {Insulin,
Dialysis}, Diagnostic {Blood Pressure, Heart Rate}, Mobility], Services
[Skilled {Primary Care, Nursing Nutritional}], Application (CVD, Diabetes,
Cancer) - Forecast to 2030,’ published by Meticulous Research®, the Latin
America home healthcare market is expected to reach $37.15 billion by 2030, at
a CAGR of 9.6% from 2023 to 2030.
Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=1287?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=12-04-2024
Home healthcare equipment and services are used to fulfill
the healthcare needs of the patient while they are at home. Home healthcare is
mostly used when a patient or individual requires prolonged care or stays in
healthcare facilities. Home healthcare includes equipment (therapeutics,
diagnostics, and mobility assistive equipment) and services (skilled home
healthcare and unskilled home healthcare) used by patients or individuals to
manage various conditions such as cardiovascular diseases, diabetes, respiratory
diseases, pregnancy, mobility disorders, and cancer. The report focuses on the
Latin American region and analyses various home healthcare equipment and
services offered by key companies in Latin America.
The Latin America home healthcare market is segmented based
on Product (Equipment [Therapeutic, Diagnostics, and Mobility Assistive
Equipment] and Services [Skilled and Unskilled]), Application (Cardiovascular
Diseases & Hypertension, Diabetes, Respiratory Diseases, Pregnancy,
Mobility Disorders, Cancer, Wound Care, and Other Conditions), and Country
(Brazil, Mexico, Argentina, Colombia, and Rest of Latin America). The study
also evaluates industry competitors and analyzes their market share at the country
level.
Based on product, in 2023, the equipment segment is expected
to account for the larger share of the Latin America home healthcare market.
This segment's large market share is attributed to the ease of use of home
healthcare equipment, the rising hospitalization costs, and the high prevalence
of chronic conditions, such as cardiovascular diseases, diabetes, and
respiratory diseases.
In 2023, the diabetes segment is expected to account for the
largest share of the Latin America home healthcare market. The large market
share of this segment is attributed to the rising prevalence of diabetes across
Latin America, the need for continuous monitoring of glucose levels among
diabetic patients, and advancements in diabetes technology. Diabetes is a major
health crisis in Latin American countries and is one of the leading causes of
death. According to the International Diabetes Federation (IDF) Diabetes Atlas
2021, the prevalence of diabetes was highest in the youth population of Brazil
and Mexico. In 2021, 15.7 million people aged 20–79 years were living with
diabetes in Brazil. This number is expected to reach 23.2 million by 2045.
Thus, the rising prevalence of diabetes across Latin America, the increasing
need for continuous monitoring of glucose levels, and advancement in diabetes
technology drive the demand for diabetes homecare equipment.
Download request sample report here: https://www.meticulousresearch.com/request-sample-report/cp_id=1287?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=12-04-2024
Based on country, the Latin America home healthcare market
is segmented into Brazil, Mexico, Argentina, Colombia, Chile, Venezuela, Peru,
Ecuador, Uruguay, and the Rest of Latin America. In 2023, Brazil is expected to
account for the largest share of the Latin America home healthcare market.
Brazil’s major market share is attributed to the high prevalence of chronic
diseases, the growing geriatric population, and the higher healthcare
expenditure in Brazil compared to other Latin American countries.
Key companies operating in the Latin America home healthcare
market are Abbott Laboratories (U.S.), Koninklijke Philips N.V. (Netherlands),
Boston Scientific Corporation (U.S.), GE HealthCare Technologies Inc. (U.S.),
Siemens Healthineers AG (Germany), Amedisys, Inc. (U.S.), LHC Group, Inc.
(U.S.), Baxter International Inc. (U.S.), Becton, Dickinson and Company (U.S.),
JOHNSON & JOHNSON (U.S.), OMRON Corporation (Japan), Fresenius SE & Co.
KGaA (Germany), and Masimo Corporation (U.S.).
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment